health π India's first dengue vaccine, Qdenga, coming in 2027
India's inaugural dengue vaccine, Qdenga, is set for release around early 2027. Takeda Pharmaceutical manufactures this live, attenuated tetravalent vaccine using recombinant DNA technology. The CDSCO granted marketing authorization after assessing its quality, safety, and efficacy. It targets people aged four to 60, though medical consultation is advised for high-risk groups. Takeda is partnering with Biological E to boost production towards 100 million doses annually by 2030.